Personalized cancer drug screening using 3D appendiceal tumor organoids
November 2018
Wake Forest Institute for Regenerative Medicine, Wake Forest School of Medicine, Winston-Salem, USA
The authors generated patient-specific appendiceal cancer tumor organoid models using tissue from biopsies. This model was used for the screening of multiple chemotherapeutics in order to find the best drug for each individual patient.
Appendiceal cancer patient-specific tumor organoid model for predicting chemotherapy efficacy prior to initiation of treatment: a feasibility study.
Aleksander Skardal
Added on: 05-22-2020
[1] https://link.springer.com/article/10.1245%2Fs10434-018-7008-2[2] https://www.technologynetworks.com/cell-science/news/patient-specific-organoid-models-appendix-cancer-treatment-313233
